Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Congressional Inquiry into Alzheimer’s Drug Faults Its Maker and F.D.A.

Por: The New York Times Health December 29, 2022

thumbnail

The Food and Drug Administration’s process for approving the Alzheimer’s drug Aduhelm, despite great uncertainty about whether it worked, was “rife with irregularities,” according to released on Thursday. The agency’s actions “raise serious concerns about F.D.A.’s lapses in protocol,” the report concluded.The 18-month investigation, initiated by two congressional committees after the F.D.A. approved the drug, also strongly... + full article



Similar News

Here's what disease does to brain, signs to look for: Alzheimer's Q&A

The Advocate USA Health January 02, 2023

thumbnailWhat is Alzheimer’s disease?German neurologist Dr. Alois Alzheimer first identified this neurological disorder in 1906 while studying the pathology of a woman he had treated for an unusual mental illness.While examining her brain after her death, Alzheimer noticed marked... + más

How To Spot The Early Signs Of Alzheimer's | Newsweek

Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes


What You Should Know About The Anti-Alzheimer’s Drug Lecanemab

Forbes USA Business December 09, 2022

thumbnailan elderly woman exercising to combat Alzheimer's disease in a care center for elderly, Galicia, ... [+] 27th November 2007. (Photo by Xurxo Lobato/Cover/Getty Images)Cover/Getty Images What should people living with dementia and their families take away from the the... + más

Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes

5 things to know about the new Alzheimer’s drug — including why it may be risky for people who take blood thinners | MarketWatch


Alzheimer's drug trial shown to slow cognitive decline in long fight against dementia

CNBC USA Health November 30, 2022

thumbnailAlzheimer's is the most common form of dementia, a general term for loss of memory, language, and other thinking abilitiesBrian B. Bettencourt Toronto Star Getty ImagesA trial of an experimental Alzheimer's drug has been hailed as a new era in the beleaguered fight to... + más

Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes

Experimental drug appears to slow progression of Alzheimer's disease but raises safety concerns | ABC7


There's a growing dementia crisis in the veteran community: Alzheimer's Q&A

The Advocate USA Health November 16, 2022

thumbnailAre U.S. veterans more at risk for Alzheimer’s or other dementias?The U.S. is in the midst of a dramatic rise in the number of veterans with Alzheimer’s disease and other dementias, and many of these new cases are directly attributable to military service.According to a 2017... + más

Stroke can lead to vascular dementia: Alzheimer's Q&A | The Advocate

Stroke can lead to vascular dementia: Alzheimer's Q&A | The Advocate


Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment

Forbes USA Tech October 22, 2022

thumbnailA person walks on a suspended rope bridge in the clouds. Extreme attraction.getty This article is the fourth installment in my series on Alzheimer’s disease. Read more about Alzheimer’s disease in , , and of the series. The pharmaceutical and biotech companies, Eisai and... + más

COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald

Variety of factors play a role in the development of Alzheimer's | The Advocate


How To Spot The Early Signs Of Alzheimer's

Newsweek USA Health September 24, 2022

thumbnailThe Alzheimer's Association defines Alzheimer's as a brain disease that causes a slow decline in memory, thinking and reasoning skills. Dementia refers to the symptoms of Alzheimer's that can worsen over time.They predict that by 2050, the number of people aged 65... + más

COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald

There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate


COVID-19 in seniors linked to increased Alzheimer’s risk, study finds

Portland Press Herald USA Health September 24, 2022

thumbnailA study using the electronic health records of more than 6 million Americans over age 65 found that those who had COVID-19 ran a greater risk of receiving a new diagnosis of Alzheimer’s disease within a year. The study, led by researchers at Case Western Reserve University... + más

There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate

How To Spot The Early Signs Of Alzheimer's | Newsweek



About iurex | Privacy Policy | Disclaimer |